蛋白质氨酸甲基转移酶1的小分子和抑制剂的结构,功能和活性
Thordur Hendrickson-Rebizant1,2, Sadhana R N Sudhakar2,3, Michael J Rowley4
1Pharmaceutical analysis Laboratory, College of Pharmacy, University of Manitoba, 750 McDermot Avenue West, Winnipeg, Manitoba R3E 0T5, Canada.
Journal of medicinal chemistry
|September 9, 2024
概括
蛋白质氨酸N-甲基转移酶 (PRMT) 调节基因表达. 这篇观点回顾了针对PRMT1的和小分子抑制剂,这是与癌症有关的关键酶,并讨论了它们的临床试验进展.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 酶学 是一种酶学.
背景情况:
- 蛋白质氨酸N-甲基转移酶 (PRMTs) 是依赖SAM的酶,可催化甲基组转移到氨酸残留物.
- PRMTs调节关键的细胞过程,包括基因表达和RNA剪接.
- 调控失调的PRMT1,一个主要的细胞氨酸甲基转移酶,与各种癌症有关.
研究的目的:
- 提供关于PRMT1.1的和小分子抑制剂的结构和功能的视角.
- 为了分析向阿尔金尼尔,SAM结合点或两者的抑制剂.
- 审查临床试验中PRMT1抑制剂的进展情况.
主要方法:
- 对PRMT1.1的选择性和小分子抑制剂的讨论.
- 检查针对基质结合部位,SAM结合部位或两者的抑制剂.
- 对特定抑制剂类 (例如N-甲基乙二胺) 的结构-活性关系的审查.
主要成果:
- 基于它们针对PRMT1结合部位和抑制类型的抑制剂的分类.
- 讨论双基质,过渡状态模仿和化抑制剂.
- 对芳香/异芳香N-甲基乙二胺抑制剂的结构-活性关系的定义.
结论:
- 由于其在细胞过程中的作用,PRMT1是癌症的重要治疗点.
- 涉及小分子和的各种策略正在开发中,以抑制PRMT1.
- 目前正在进行的研究和临床试验表明,PRMT1抑制剂在癌症治疗中具有前景.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
542
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
542
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


